MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    Utilization of Skin Punch Biopsy for the Diagnosis of Alpha-synucleinopathy in Clinical Practice

    C. Gummerson, S. Tinaz, V. Santini, A. Zubair (New Haven, USA)

    Objective: To understand the use of skin punch biopsies for diagnosis and management of α-synucleinopathy within a large medical system. Background: Skin punch biopsy has…
  • 2024 International Congress

    AI for Personalized Medication Management in Parkinson’s Disease

    R. Diaz-Rincon, H. Khoshbouei, B. Shickel (Gainesville, USA)

    Objective: To assess medication usage over time in Parkinson’s Disease utilizing AI in EHR data. Background: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized…
  • 2024 International Congress

    α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease

    D. Coughlin, B. Shifflett, A. Siderowf, S. Edland, D. Galasko, C. Farris, Y. Ma, C. Soto, L. Concha-Marambio (San Diego, USA)

    Objective: To examine the relationship between the reaction parameters of the cerebrospinal fluid (CSF) αSyn seed amplification assay (αSyn-SAA) to the risk of developing motor…
  • 2024 International Congress

    Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of the first interventional study in  Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…
  • 2024 International Congress

    Manganese-induced Parkinsonism Vs Rotenone-induced Parkinsonism: Animal Life Matters!

    S. Chib (Bathinda, India)

    Objective: To evaluate the Parkinsonism mimicking potential of MnCl2 in an experimental rat model.To compare the destructive effect of MnCl2 with rotenone by performing behavioral,…
  • 2024 International Congress

    Clinical Profile of Motor Complications in Parkinson’s Disease Patients at A National Tertiary Hospital In Indonesia

    Y. Rapri, A. Jody, A. Tiksnadi, D. Tunjungsari (Depok, Indonesia)

    Objective: To analyse factors associated with motor complications in Parkinson's disease at a national tertiary referral hospital in Indonesia. Background: As Parkinson's disease progresses, levodopa…
  • 2024 International Congress

    Oral health in Parkinson’s disease patients from countries with different economies: preliminary results of the OralPark study.

    S. Rota, L. Batzu, A. Biondi, I. Boura, D. Urso, S. Diaconu, Y. Lau, I. Inês, P. Tall, P. Lyra, S. Puspasari, S. Gilani, P. Zinzalias, L. Neumaier, P. Pablo, C. Santoro, S. Landolfo, K. Popławska-Domaszewicz, C. Spanaki, P. Odin, DK. Sreenivas, LK. Prashanth, C. Falup-Pecurariu, A. Rizos, J. Botelho, KR. Chaudhuri (UK, United Kingdom)

    Objective: To characterize oral health in Parkinson’s disease (PD) patients from countries with different economies. Background: Oral diseases are the most frequent conditions globally and…
  • 2024 International Congress

    Changes in Postural Control of Patients with Normal Pressure Hydrocephalus After Lumbar Puncture

    Z. Kosutzka, I. Straka, L. Hapakova, J. Pucik, M. Saling (Bratislava, Slovakia)

    Objective: To evaluate the alterations in postural control among patients diagnosed with normal pressure hydrocephalus (NPH) following lumbar puncture Background: Posturography is an indispensable tool…
  • 2024 International Congress

    Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson’s Disease: Case Study

    R. Pessoa, L. Cidral, E. de Souza, M. Marchiori (Curitiba, Brazil)

    Objective: The aim of this research is to assess unilateral pallidotomy as a surgical alternative for Parkinson's Disease (PD), emphasizing improvements in contralateral motor symptoms…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #25676 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley